
Imatib Imatinib
Imatib Imatinib (400mg) oral solid — targeted therapy for chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). WHO-GMP certified, export-ready.
400mg
Imatib Imatinib 400mg
10 Tablets per strip
NexCure Health
Pricing and availability are confirmed by our team after checking the product, quantity, destination rules, and required documentation.
Bulk quotes, documentation, and shipping options are handled manually after prescription, buyer, and destination checks where applicable.
Manufactured by NexCure Health, 400mg Imatib Imatinib Tablets IP is a pharmaceutical-grade targeted therapy product containing Imatib Imatinib 400mg. The active ingredient functions as a tyrosine kinase inhibitor that blocks BCR-ABL fusion protein activity, making it effective for chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). This product is produced under strict GMP conditions with complete batch traceability. Export-ready with Certificate of Analysis, stability data, and documentation required for international pharmaceutical import.